Showing posts with label Dr Karen Alt. Show all posts
Showing posts with label Dr Karen Alt. Show all posts

1 Dec 2021

Imaging competition winners announced!

Magnetic Particle Imaging (MPI) of Xenograft Mouse
by Ms Jurie Tashkandi
The 2021 Monash Biomedical Imaging (MBI) image competition celebrated outstanding scanner images obtained at MBI and Alfred Research Alliance – Monash Biomedical Imaging (ARA-MBI).

Congratulations to the winners: Ms Jennifer Tinston (PhD student in the Epilepsy and Behaviour group, Department of Neuroscience), Ms Jurie Tashkandi (PhD student in the Nanotheranostics group in the Australian Centre for Blood Diseases), Dr Bianca Jupp, Dr Karen Alt and Dr Chao Suo

View the winning entries on the MBI website with additional information about each image.

21 Oct 2021

From little things, bigger things grow: ACBD CARE program expands to CCS

The Central Clinical School's CARE schematic

The concept of research and consumer partnerships is not a new one, but the scientific community has increasingly recognised its importance in recent years, with a growing proportion of funding bodies now recommending or requiring consumer engagement for grant pitches. 

The Central Clinical School's Consumer and Researcher Engagement (CCS CARE) program initially developed by researchers and staff within Australian Centre for Blood Diseases (ACBD), is now seeing a growth and roll out at the school-wide level. This growth is remarkable given that the CARE program was only officially launched in February of this year (ccsmonash.blogspot.com/2021/03/launch-of-acbds-community-engagement.html).

13 Oct 2021

Video: Blood not bone marrow? The potential role for blood testing to improve Multiple Myeloma diagnosis and therapy

 
Prof Andrew Spencer, Dr Durga Mithraprabhu &
Dr Nick Bingham
explain the research for liquid biopsy
 vs bone marrow test for multiple myeloma.
See video 1:30:12 hours

The CCS Consumer Engagement committee hosted our first community webinar on 7 October - "Blood not bone marrow? The potential role for blood testing to improve Multiple Myeloma diagnosis and therapy". See webinar video.

Presentations were given by members of the Spencer lab in the Australian Centre for Blood Diseases, as well as their consumer partner Mr Henry Blatman and a representative of Myeloma Australia, Ms Hayley Beer.

Related Posts Plugin for WordPress, Blogger...